View in EDS HTML Full Text PDF Full Text

Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.

Saved in:
Bibliographic Details
Title: Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
Authors: Richter AG; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Shields AM; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Karim A; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Birch D; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Faustini SE; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Steadman L; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Ward K; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Plant T; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Reynolds G; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Veenith T; Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, Birmingham, UK., Cunningham AF; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Drayson MT; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Wraith DC; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Source: Clinical and experimental immunology [Clin Exp Immunol] 2021 Aug; Vol. 205 (2), pp. 99-105. Date of Electronic Publication: 2021 Jun 13.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 0057202 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2249 (Electronic) Linking ISSN: 00099104 NLM ISO Abbreviation: Clin Exp Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34082475
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Richter+AG%22">Richter AG</searchLink>; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Shields+AM%22">Shields AM</searchLink>; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Karim+A%22">Karim A</searchLink>; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Birch+D%22">Birch D</searchLink>; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Faustini+SE%22">Faustini SE</searchLink>; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Steadman+L%22">Steadman L</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Ward+K%22">Ward K</searchLink>; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Plant+T%22">Plant T</searchLink>; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Reynolds+G%22">Reynolds G</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Veenith+T%22">Veenith T</searchLink>; Department of Critical Care Medicine, University Hospitals Birmingham NHS Trust, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Cunningham+AF%22">Cunningham AF</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Drayson+MT%22">Drayson MT</searchLink>; Clinical Immunology Service, Institute for Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Wraith+DC%22">Wraith DC</searchLink>; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220057202%22">Clinical and experimental immunology</searchLink> [Clin Exp Immunol] 2021 Aug; Vol. 205 (2), pp. 99-105. <i>Date of Electronic Publication: </i>2021 Jun 13.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0057202 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1365-2249 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200099104%22">00099104 </searchLink><i>NLM ISO Abbreviation: </i>Clin Exp Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34082475
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1111/cei.13623
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 99
    Titles:
      – TitleFull: Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Richter AG
      – PersonEntity:
          Name:
            NameFull: Shields AM
      – PersonEntity:
          Name:
            NameFull: Karim A
      – PersonEntity:
          Name:
            NameFull: Birch D
      – PersonEntity:
          Name:
            NameFull: Faustini SE
      – PersonEntity:
          Name:
            NameFull: Steadman L
      – PersonEntity:
          Name:
            NameFull: Ward K
      – PersonEntity:
          Name:
            NameFull: Plant T
      – PersonEntity:
          Name:
            NameFull: Reynolds G
      – PersonEntity:
          Name:
            NameFull: Veenith T
      – PersonEntity:
          Name:
            NameFull: Cunningham AF
      – PersonEntity:
          Name:
            NameFull: Drayson MT
      – PersonEntity:
          Name:
            NameFull: Wraith DC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 08
              Text: 2021 Aug
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1365-2249
          Numbering:
            – Type: volume
              Value: 205
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: Clinical and experimental immunology
              Type: main
ResultId 1